GLG1 and Ewing sarcoma: While CD99 showed broad expression in many different tumor entities, ATP1A1, BCL11B, and GLG1 were only expressed at low levels in every tumor entity relative to Ewing sarcoma, indicating a higher specificity for this disease than CD99 (Figure 1C).